California's $3 billion stem cell institute is not likely to offer any medical cures for at least another 10 years, according to a group assigned to draft a strategic plan. The group's proposal, which must be approved by the California Institute for Regenerative Medicine, spells out a method for eventually turning stem cells into treatments and anticipates early studies on potential cures having just begun before the funds run out.

Related Summaries